Sanofi is pursuing research to explore protection at various stages of life and find solutions for different age groups.
Public source
Publisher name
Public post
With respiratory viruses, what we see — a cough, a fever, a difficult night — is just the beginning. The real breakthroughs happen when we explore the complex patterns b…
Company
Sanofi
- Industry
- Pharmaceutical Manufacturing
- Location
- Paris, FR
- Company size
- 10,001+ employees
About Sanofi
We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms
See moreLatest activity
Latest activity from Sanofi
67 signals
Research & Knowledge
Sanofi spent a lot of time modeling where an HCP is in their journey, including mapping awareness, consideration, trial, and adoption.
Research & Knowledge
Sanofi remains committed to advancing understanding of immune thrombocytopenia (ITP) and supporting the communities affected by it.
Legal & Regulatory
Sanofi noted that Autistici/Inventati, a privacy-focused technology collective, was suspended by the US-based registry and its Italian bank account frozen and closed due to sanctions risk.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
AstraZeneca
AstraZeneca is investing in science focused on factors contributing to uncontrolled hypertension and interconnected disease.
Research & Knowledge
Servier
Servier's R&D budget is 70% dedicated to oncology with a strong focus on rare cancers.
Research & Knowledge
Bristol Myers Squibb
Bristol Myers Squibb has been researching potential therapies for people living with pulmonary fibrosis for more than a decade and is building on that progress.
Research & Knowledge
Jazz Pharmaceuticals
Jazz Pharmaceuticals is redefining the treatment of difficult-to-treat cancers by focusing on innovative areas of research like targeted therapy.
Research & Knowledge
Novo Nordisk